Wellington Management Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-64,830
Closed -$730K 2008
2025
Q2
$730K Sell
64,830
-10,159,381
-99% -$93.3M ﹤0.01% 1758
2025
Q1
$96.8M Sell
10,224,211
-212,284
-2% -$2.14M 0.02% 509
2024
Q4
$117M Sell
10,436,495
-2,158,964
-17% -$37.9M 0.02% 497
2024
Q3
$356M Buy
12,595,459
+1,426,747
+13% +$36.8M 0.06% 263
2024
Q2
$214M Buy
11,168,712
+2,315,081
+26% +$59.1M 0.04% 365
2024
Q1
$290M Buy
8,853,631
+540,474
+7% +$17.2M 0.05% 320
2023
Q4
$275M Buy
8,313,157
+4,073,959
+96% +$115M 0.05% 325
2023
Q3
$115M Buy
4,239,198
+449,664
+12% +$12.5M 0.02% 487
2023
Q2
$115M Buy
3,789,534
+1,290,099
+52% +$41.7M 0.02% 513
2023
Q1
$81.1M Buy
2,499,435
+1,189,594
+91% +$37.6M 0.02% 589
2022
Q4
$36.8M Buy
1,309,841
+605,810
+86% +$17.4M 0.01% 758
2022
Q3
$25.3M Buy
704,031
+51,513
+8% +$1.81M 0.01% 848
2022
Q2
$20M Buy
+652,518
New +$19M ﹤0.01% 944
2020
Q2
Sell
-1,470,988
Closed -$7.99M 1886
2020
Q1
$7.99M Sell
1,470,988
-2,169,812
-60% -$19.4M ﹤0.01% 1090
2019
Q4
$32.9M Buy
3,640,800
+1,987,812
+120% +$16.1M 0.01% 867
2019
Q3
$11.9M Buy
1,652,988
+1,611,205
+3,856% +$11.6M ﹤0.01% 1106
2019
Q2
$332K Sell
41,783
-569
-1% -$6.74K ﹤0.01% 1965
2019
Q1
$533K Sell
42,352
-18,312
-30% -$290K ﹤0.01% 1890
2018
Q4
$1.21M Sell
60,664
-2,012
-3% -$46.5K ﹤0.01% 1762
2018
Q3
$1.78M Buy
62,676
+10,578
+20% +$252K ﹤0.01% 1732
2018
Q2
$1.1M Buy
52,098
+1,124
+2% +$21.3K ﹤0.01% 1870
2018
Q1
$726K Buy
50,974
+4,038
+9% +$57.8K ﹤0.01% 1954
2017
Q4
$577K Buy
46,936
+17,605
+60% +$248K ﹤0.01% 2017
2017
Q3
$523K Buy
+29,331
New +$604K ﹤0.01% 2031

Other funds holding EVH

Wellington Management Group's EVH Position: Q3 2025 in Review

Wellington Management Group sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 64,830 shares — an estimated $730K sold.

Wellington Management Group first reported a position in EVH in Q3 2017 and held it in 24 quarters. The position peaked at $356M in Q3 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Wellington Management Group reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 64,830 Evolent Health shares in Q3 2025, an estimated $730K.
  • Wellington Management Group first reported a position in Evolent Health in Q3 2017 and held it in 24 quarters.
  • Wellington Management Group's Evolent Health position peaked at $356M in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.